This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 203,14 per year only 16,93 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
For instance, in a recent Phase 3 trial of the glucagon-like peptide 1 (GLP-1) agonist semaglutide, researchers hypothesized that reducing inflammation throughout the body could head off cognitive decline in early Alzheimers
The body maintains tight copper homeostasis through ceruloplasmin binding and hepatic processing
[DOI] [PubMed] [Google Scholar] 5.Bunch SE, Johnson SE, Cullen JM
Kiinin ihtiya duyduu glutatyon dozu vcuda zarar vermez
Diabetes Metab (2014) 40:1917